Table 1.
Cases of infective endocarditis in patients with hereditary hemorrhagic telangiectasia
| Ref. | Age | Sex | Infected valve | Pathogen | Antibiotics | Surgery | Outcome |
|---|---|---|---|---|---|---|---|
| [9] | 62 | F | Mitral (prosthetic) | S. mitis | Piperacillin + cefazolin | MVR | Survived |
| [10] | 79 | F | Mitral | S. aureus | Oxacillin | MVR | Dead |
| [11] | 73 | M | Aortic (prosthetic) | Unknown | Unknown | AVR | Survived |
| [12] | 69 | M | Mitral | S. aureus | Oxacillin | – | Survived |
| [13] | 61 | F | Aortic (prosthetic) | S. aureus | Unknown | AVR | Survived |
| [14] | 65 | F | Aortic (prosthetic) | S. epidermidis | Unknown | AVR | Survived |
| [15] | 65 | M | Pulmonary | S. epidermidis | Rifampin + linezolid | Valvuloplasty | Survived |
| [16] | 65 | F | Aortic (Prosthetic) | L. rhamnosus | Amoxicillin/clavulanate + gentamicin | – | Survived |
S. mitis: Streptococcus mitis, S. aureus: Staphylococcus aureus, S. epidermidis: Staphylococcus epidermidis, L. rhamnosus: Lactobacillus rhamnosus, HHT hereditary hemorrhagic telangiectasia, F female, M male, MVR mitral valve replacement, AVR aortic valve replacement